* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected to show a
rise in quarterly revenue when it reports results on August 4
(estimated).
* The Lakewood, Colorado-based company is expected to report a
13.9% increase in revenue to $34.1 million from $29.94 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Mesa Laboratories Inc
is for earnings of 10 cents per share. For the same quarter last
year, the company reported earnings of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Mesa
Laboratories Inc is $280, about 5.2% below its last closing
price of $294.51.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.18 0.26 0.74 Beat 190.2
Dec. 31 2020 0.32 0.33 -0.89 Missed -373.8
Sep. 30 2020 0.04 0.06 0.51 Beat 705.3
Jun. 30 2020 0.89 0.76 0.22 Missed -71.1
Mar. 0.17 0.21 0.06 Missed -71
31 2020
Dec. 31 2019 1.29 1.00 -1.06 Missed -206.3
Sep. 30 2019 0.80 0.81 0.71 Missed -12
Jun. 30 2019 0.84 0.85 1.13 Beat 33.7
This summary was machine generated August 2 at 14:25 GMT. All
figures in US dollars unless otherwise stated